CardieX is a digital healthcare company redefining the way hypertension, cardiovascular disease (CVD), and other major vascular diseases are clinically diagnosed and managed. Our vision is to be the leading provider of home, wearable, healthcare, clinical trial, and remote patient monitoring solutions for the world’s most common health disorders including hypertension, CVD, Alzheimer’s disease, chronic kidney disease (CKD), and other major vascular health conditions.

Our SphygmoCor vascular biometric technology measures arterial health by collecting clinically meaningful digital vascular biomarkers using novel sensors. These biomarkers represent key indicators of vascular health including, but not limited to, central blood pressures (cBP), vascular stiffness, vascular age, and heart stress. SphygmoCor is trusted by certain of the world’s largest pharmaceutical companies and healthcare systems to measure arterial health.